| Literature DB >> 29854089 |
Joanna Kocot1, Małgorzata Kiełczykowska1, Dorota Luchowska-Kocot1, Jacek Kurzepa1, Irena Musik1.
Abstract
Honeybees products comprise of numerous substances, including propolis, bee pollen, and royal jelly, which have long been known for their medicinal and health-promoting properties. Their wide biological effects have been known and used since antiquity. Bee products are considered to be a potential source of natural antioxidants such as flavonoids, phenolic acids, or terpenoids. Nowadays, the still growing concern in natural substances capable of counteracting the effects of oxidative stress underlying the pathogenesis of numerous diseases, such as neurodegenerative disorders, cancer, diabetes, and atherosclerosis, as well as negative effects of different harmful factors and drugs, is being observed. Having regarded the importance of acquiring drugs from natural sources, this review is aimed at updating the current state of knowledge of antioxidant capacity of selected bee products, namely, propolis, bee pollen, and royal jelly, and of their potential antioxidant-related therapeutic applications. Moreover, the particular attention has been attributed to the understanding of the mechanisms underlying antioxidant properties of bee products. The influence of bee species, plant origin, geographic location, and seasonality as well as type of extraction solutions on the composition of bee products extracts were also discussed.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29854089 PMCID: PMC5954854 DOI: 10.1155/2018/7074209
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1The examples of flavonoids and their glycosides detected in bee products. Quercetin, naringenin, isorhamnetin, and kaempferol: detected in propolis, bee pollen, royal jelly; galangin and pinocembrin: detected in propolis and bee pollen; pinobanksin: detected in propolis and royal jelly; luteolin, apigenin, and rutin: detected in propolis, bee pollen, and royal jelly; catechin and delphinidin: detected in bee pollen; daidzein: detected in propolis [29, 32, 74, 78, 83, 103].
Figure 2The examples of phenolic acids and their derivatives found in bee products: (a) benzoic acid derivatives and (b) cinnamic acid derivatives. Protocatechuic acid, syringic acid, gallic acid, p-coumaric acid: detected in propolis and bee pollen; caffeic acid and ferulic acid: detected in propolis, bee pollen, and royal jelly; artepillin C, chlorogenic acid, and 3,5-dicaffeoylquinic acid: detected in propolis [28, 41, 71, 74, 78, 102, 139].
Figure 3The examples of amyrins found in propolis [19, 20].
Figure 4The main carboxylic acids of the royal jelly and their derivatives [23, 24, 105].
The results of the research on the dependence between the solvent used for the extraction and the antioxidant properties of the obtained propolis and bee pollen extracts.
| Source | Type of bee products | The used solvents | The dependence between the used extraction solvent and the properties of the obtained extract |
|---|---|---|---|
| Bittencourt et al. [ | Green and brown Brazilian propolis | Ethanol (95%) extraction, evaporation, and dissolving in 80% ethanol and then partitioning with hexane or dichloromethane. | Antioxidant activity showed considerable differences depending on the used solvent and propolis type. |
| Narimane et al. [ | Algerian propolis collected from Beni Belaid, Jijel (northeast of Algeria) | CH2Cl2-MeOH (1 : 1, | The DPPH, ABTS, FRAP, and CUPRAC methods were applied to determine antioxidant activity. |
| Sun et al. [ | Beijing propolis | Water, 25%, 50%, 75%, 95%, and 100% ethanol. | The 75% extract demonstrated the highest antioxidant capacity measured by DPPH, ABTS, FRAP, ORAC, and CAA methods. |
| LeBlanc et al. [ | Six pollen types (mesquite, yucca, palm, terpentine bush, mimosa, and chenopod) collected in Arizona between March and November | Water, methanol, ethanol, propanol, 2-propanol, acetone, dimethylformamide, and acetonitrile. | Antioxidant activity showed considerable differences depending on the used solvent. |
| Silva et al. [ | Pollen loads collected from | Fractional extraction with subsequent using of ethanol, n-hexane, and ethyl acetate. | The DPPH method was applied to determine antioxidant activity. |
| Chantarudee et al. [ | Bee pollen collected in Thailand in the summer (June), its main component being identified as pollen of corn ( | Subsequent application of 80% methanol, dichloromethane, and hexane. | The antioxidant activity of the obtained extracts was estimated by DPPH assay. |
| Maruyama et al. [ | Bee pollen from | Water and 95% ethanol | In rats with induced hind paw edema, the oral administration of bee pollen water extract had practically no effect, while ethanol extract displayed the greatest effectiveness in the inhibition of paw edema. |
The protective effects of propolis against prooxidant action of different harmful factors.
| Source | Toxic or harmful factor | Harmful effects of an applied factor | The type of propolis and the way of application | Effects of propolis coadministration |
|---|---|---|---|---|
| Neuroprotective effect of propolis | ||||
| Bazmandegan et al. [ | Cerebral ischemia-induced oxidative injury in a mouse model of stroke | ↑ MDA | Water-extracted Iran brown propolis; from two regions of Iran; 100 and 200 mg/kg; | ↓ MDA |
| Ni et al. [ | H2O2-induced neurotoxicity, human neuroblastoma SH-SY5Y cells (100 | ↑ ROS in mitochondria | Methanol extract of Brazilian green propolis, 10 | ↓ ROS in mitochondria |
| Nanaware et al. [ |
| ↓ SOD, GSH, CAT, NO | Macerated ethanolic extract of Indian propolis; 100, 200, and 300 mg/kg b.w., | ↑ SOD, GSH, CAT, NO |
| Jin et al. [ | 6-Hydroxydopamine-induced oxidative stress in human neuroblastoma SH-SY5Y cells (50 | ↑ ROS | Pinocembrin; 1, 5, and 25 | ↓ ROS∗∗ |
| de Oliveira et al. [ | Paraquat-induced neurotoxicity in SH-SY5Y cells (100 | ↑ O2−• production, lipid peroxidation, protein carbonylation, and protein nitration in mitochondrial membranes | Pinocembrin; 25 | ↓ O2−• production, lipid peroxidation, protein carbonylation, protein nitration, as well as oxidation of thiol groups in mitochondrial membranes |
| Barros Silva et al. [ | 6-OHD-induced dopaminergic neuronal loss in rats, (3 | ↑ Hydrogen peroxide in striatum | Caffeic acid phenethyl ester (CAPE); 10 | ↓ Hydrogen peroxide in striatum |
| Mahmoud et al. [ | K2CrO4-induced neurotoxicity in rats, (2 mg/kg b.w. for 30 days, | ↑ MDA and NO | CAPE 20 mg/kg b.w. cotreatment for 30 days, orally | ↓ MDA and NO |
| Propolis role in mitigation of chemotherapy side effect | ||||
| Kumari et al. [ | Mitomycin C-induced testicular toxicity in male mice, (8 mg/kg b.w., | ↑ MDA | Hydroethanolic extract of Indian propolis pretreatment (1 h prior) 400 mg/kg, | ↓ MDA |
| Alyane et al. [ | Doxorubicin-induced toxicity in rat heat mitochondria, (20 mg/kg b.w., | ↑ Mitochondrial MDA | Propolis extract pretreatment with 100 mg/kg/day, | ↓ Mitochondrial MDA |
| Propolis as a modulator of cardiovascular disease markers | ||||
| Salmas et al. [ | N | ↓ TAS, PON1 | Propolis CAPE coadministration: propolis: 200 mg/kg/d; 28 days, by gavage; CAPE: 50 | ↑ TAS |
| Ahmed et al. [ | Isoproterenol-induced myocardial infarction in rats, (85 mg/kg injection for 2 days—on the 29th and 30th days) | ↓ SOD, GPx, GRx, and GST in myocardium | Malaysian propolis ethanol extract, pretreatment with 100 mg/kg/day, orally, 30 days | ↑ GPx, GRx, and GST in myocardium |
| Sun et al. [ | H2O2-induced rat cardiomyocytes (H9c2) oxidative injury, (700 | ↑ MDA | CAPE, benzyl caffeate, and cinnamyl caffeate pretreatment with 1, 5, and 10 | ↓ MDA—doses of 5 and 10 |
| El-Awady et al. [ | High glucose-induced vascular endothelial dysfunction, isolated rat aorta, (44 mM for 3 hours) | ↑ TBARS in rat aorta | Propolis extract pretreatment 400 | ↓ TBARS in rat aorta |
| Propolis as protective agent against prooxidants' toxicity | ||||
| Yonar et al. [ | Trichlorfon-induced oxidative stress in fish, environmental exposure, 11 and 22 mg/L, 14 days | ↑ MDA in the liver, kidney, and gill | Propolis cotreatment 10 mg/kg of fish weight, 14 days | ↓ MDA in the liver, kidney, and gill |
| Ferreira et al. [ | Tebuconazole-induced oxidative stress in fish, environmental exposure (0.88 mg/L) | ↑ MDA and carbonyl protein in brain, liver, and kidney | Propolis; 0.01, 0.05, and 0.1 g/L | ↓ MDA and carbonyl protein in brain, liver and kidney |
| Aksu et al. [ | Paracetamol- (PRC-) induced reproductive toxicity in rats, (500 mg/kg b.w., by oral gavage) | ↓ SOD, CAT, GPx, and GSH in testicular tissue | Chrysin; pretreatment with 25 mg/kg and 50 mg/kg b.w., by oral gavage, 7 days | ↑ GSH, CAT∗∗, GPx∗∗, SOD (only the higher dose) in testicular tissue |
| Manzolii et al. [ | Methylmercury-induced oxidative stress (30 | ↓ GSH in blood | Chrysin; cotreatment (0.10, 1.0, and 10 mg/kg b.w., by gavage, 45 days) | ↑ GSH in blood |
| Saito et al. [ | UVA irradiation, human skin fibroblast cells—NB1-RGB (10 J/cm2) | ↑ HO-1 expression | Brazilian green propolis; 3, 10, or 30 | ↑ HO-1 expression |
| Cao et al. [ | H2O2-induced oxidative stress, mouse L929 fibroblast cell lines, (600 | ↑ ROS | Ethanol extract of Chinese propolis; pretreatment with 5, 7.5, and 10 | ↓ ROS∗∗ |
| Arabameri et al. [ | Maternal separation-induced stress, the neonatal rats, separated 6 hours per day, 15 days | ↑ MDA in ovarian tissue | Iranian propolis; cotreatment 50, 100, or 200 mg/kg b.w.; 15 days | ↓ MDA∗∗ in ovarian tissue |
| Zhang et al. [ | H2O2-induced oxidative stress, RAW264.7 cells, 300 | ↑ Intracellular ROS | Two ethanol extracts of Chinese propolis, pretreatment for 0.5 hour before | ↓ Intracellular ROS |
| RAW264.7 cells not subjected to any factor | ———— | Two ethanol extracts of Chinese propolis | ↓ Intracellular ROS |
ADMA: asymmetric dimethylarginine; Bax: Bcl-2-related ovarian killer protein; Bcl-2: B-cell lymphoma 2; CAT: catalase; GCLC: glutamate-cysteine ligase catalytic subunit; GCLM: glutamate-cysteine ligase regulatory subunit; Erk 1/2: extracellular signal-regulated kinase ½, FRAP: ferric reducing ability; GPx: glutathione peroxidase; GRx: glutathione reductase; GSH: reduced glutathione; GST: glutathione reductase; HO-1: heme oxygenase-1; JAK 2: Janus kinase 2; MDA: malondialdehyde; NF-κB: nuclear factor kappa B; Nrf2: nuclear factor erythroid 2-related factor 2 (Nrf2); NO: nitric oxide; 8-oxo-2′-deoxyguanosine, P/O: phosphate/oxygen ratio; PON1: paraoxonase; RCR: respiratory control ratio; ROS: reactive oxygen species; STAT3: signal transducer and activator of transcription 3; SOCS3: suppressor of cytokine signaling 3; SOD: superoxide dismutase; TAS: total antioxidant status; TBARS: thiobarbituric acid reactive substances; TOS: total oxidant status; TrxR1: thioredoxin reductase 1; γ-GCS: γ-glutamylcysteine synthetase. ↓: decrease; ↑: increase; ∗∗the effect depended on used dose.
The protective effects of bee pollen against prooxidant action of different harmful factors.
| Source | Toxic factor | Harmful effects of a toxic factor | The type of bee pollen and the way of application | Effects of bee pollen coadministration |
|---|---|---|---|---|
| Mitigation effect of bee pollen on chemiotherapeutic agents | ||||
| Huang et al. [ | Cisplatin-induced toxicity in rats, (8 mg/kg b.w. | ↑ MDA and iNOS: liver and kidney |
| ↓ MDA in liver∗∗ and kidney |
| Tohamy et al. [ | Cisplatin-induced toxicity in male mice (2.8 mg/kg b.w. | ↑ Lipid peroxidation in liver, kidney and testis | Water, Egyptian bee pollen extract, 140 mg/kg b.w. once a day orally, during the last 2 weeks of cisplatin exposure | ↓ Lipid peroxidation in the kidney, liver, and testis |
| Mitigation effect of bee pollen on other toxic agents | ||||
| Ferreira et al. [ | Tebuconazole-exposed fish (catfish jundiá), 0.88 mg/L (16.6% of 96 h LC50) | ↑ Lipid peroxidation in the liver, kidney, and brain | Bee pollen; 0.01, 0.03, and 0.05 g/L, environmental exposure | ↓ Lipid peroxidation in the liver, kidney∗∗, and brain∗∗ |
| Yıldız et al. [ | Carbon tetrachloride-induced hepatotoxicity in rats (0.85 mL/kg b. w. | ↑ plasma ALT and AST | Bee pollen collected during flowering season in Turkey (Western Black Sea region) with dominant component chestnut | ↓ Plasma ALT: high dose |
| Almaraz-Abarca et al. [ | Bromobenzene-induced hepatotoxicity in mice, 94.211 | ↑ Lipid peroxidation liver | Bee pollen from mesquite ( | ↓ Liver lipid peroxidation—only the higher dose |
| Ketkar [ | Chronic exercise-induced oxidative stress in rats, 4 weeks | ↓ Gastrocnemius muscle SOD and GSH | The neat and processed (1 mg of bee pollen : 500 mg of Captex 355 : 750 mg of Tween 80) monofloral Indian mustard bee pollen, 100, 200, or 300 mg/kg daily, orally | ↑ SOD and GSH in gastrocnemius muscle |
ALT: alanine aminotransferase; AST: aspartate aminotransferase; CAT: catalase; GSH: reduced glutathione, iNOS: inducible nitric oxide synthase; MDA: malondialdehyde; NO: nitrogen oxide; RBC: red blood cell; SOD: superoxide dismutase; ↓: decrease; ↑: increase; ∗∗the effect depended on used dose.
The protective effects of royal jelly against prooxidant action of different harmful factors.
| Source | Toxic/harmful factor | Harmful effects of an applied factor | The dose and the way of application of royal jelly or its ingredients | Effects of royal jelly or its ingredient coadministration |
|---|---|---|---|---|
| Neuroprotective effect of royal jelly | ||||
| Mohamed et al. [ | Tartrazine-induced neurotoxicity in rats (500 mg/kg | ↑ MDA; ↓ SOD, CAT, and GSH in brain tissue | RJ: 300 mg/kg | ↓ MDA; ↑ SOD, CAT, and GSH in brain tissue |
| Aslan et al. [ | Neuronal damage after experimental spinal cord injury (laminectomy) in rabbits | ↓ Nitrate and nitrite in serum | RJ: 100 mg/kg b.w. | ↓ MDA, ↑GSH in whole blood |
| Teixeira et al. [ | Resistant and cold stress condition | ↑ TBARS brain, cerebellum, cerebral cortex, and hippocampus | RJ: 200 mg/kg by gavage, 14 days | ↓ TBARS level in the brain, cerebellum, striatum, and hippocampus |
| Inoue et al. [ | 6-Hydroxydopamine- (6OHDA-) induced cell death; human neuroblastoma SH-SY5Y cells | ↑ ROS generation | RJ fatty acid derivative—HPO-DAEE: 50 | ↑ Expression of HO-1 mRNA |
| Mitigation effect of royal jelly on chemotherapeutic agents | ||||
| Silici et al. [ | Cisplatin-induced spermiotoxicity in rats (7 mg/kg b.w. | ↑ MDA | RJ pretreatment and posttreatment: 50 or 100 mg/kg b.w. | ↓ MDA |
| Silici et al. [ | Cisplatin-induced nephrotoxicity in rats (7 mg/kg | ↑ MDA | RJ pretreatment and posttreatment: 50 or 100 mg/kg b.w. | ↓ MDA |
| Amirshahi et al. [ | Bleomycin-induced spermiotoxicity in rats (10 mg/kg b.w., 48 days, twice a week, | ↑ MDA in testicular tissue | RJ: 100 mg/kg b.w., | ↓ MDA in testicular tissue |
| Kaynar et al. [ | Methotrexate-induced oxidative stress in rats (20 mg/kg b.w. | ↑ MDA and ↓ SOD and GPx in plasma | RJ: 50 or 100 mg/kg b.w., | ↓ MDA and ↑ SOD∗∗ and GPx∗∗ in plasma |
| Malekinejad et al. [ | Paclitrexal-induced cardiotoxicity in rats (7.5 mg/kg b.w. | ↓ TAC in serum | RJ: 50, 100, or 150 mg/kg b.w., | ↑ TAC∗∗ in serum |
| Delkhoshe-Kasmaie et al. [ | Taxol-induced damage of the testis (7.5 mg/kg b.w. | ↑ MDA and NO and ↓ TTM in testis tissue | RJ: 50, 100, or 150 mg/kg b.w., 4 weeks | ↓ MDA and NO∗∗ and ↑ TTM∗∗ in testis tissue |
| Mitigation effect of royal jelly on other toxic agents | ||||
| Kanbur et al. [ | Sodium fluoride-induced oxidative stress in mice (200 ppm fluoride | ↑ MDA in erythrocytes and liver tissue | RJ: 50 mg/kg b.w. by gavage for 7 days | ↓ MDA in erythrocytes and liver tissue |
| Cemek et al. [ | Carbon tetrachloride-induced acute liver damage in rats (0.8 mL/kg b.w. | ↑ MDA in the whole blood, liver, brain, kidney, lung, and heart tissues | RJ: 50, 100, and 200 mg/kg b.w., | ↓ MDA in the whole blood, liver∗∗, brain∗∗, kidney, lung, and heart tissues |
| Ahmed et al. [ | Azathioprine-induced toxicity in rats (50 mg/kg b.w. | ↑ MDA and GSH in the liver tissue | RJ: 200 mg/kg | ↓ MDA and ↑ GSH in the liver tissue after 24 h and 2 weeks of posttreatment |
| Ghanbari et al. [ | Streptozotocin-induced diabetes mellitus (60 mg/kg b.w., | ↑ MDA, ↓ CAT, and FRAP in the liver and pancreas | RJ: 200 mg/kg b.w., | ↓ MDA in the liver and pancreas |
| Ghanbari et al. [ | Streptozotocin-induced diabetes mellitus (50 mg/kg b.w., | ↓ CAT and FRAP in testicular tissue | RJ: 200 mg/kg b.w., | ↑ CAT and FRAP in the testicular tissue |
| Sugiyama et al. [ | LPS- and interferon- | ↑ Nitrate | RJ fatty acid (1 mM, 2 mM, 4 mM 10H2DA) | ↓ Nitrate |
| Takahashi et al. [ | Interferon- | ↑ Nitrate | RJ fatty acid (1 mM, 2 mM, 5 mM 10H2DA) | ↓ Nitrate |
10H2DA: 10-hydroxy-trans-2-decenoic acid; CAT: catalase; FRAP: iron reduction capacity; G6PDH: glucose-6-phosphate dehydrogenase; GPx: glutathione peroxidase; GR: glutathione reductase; GSH: reduced glutathione; G6PDH: glucose-6-phosphate dehydrogenase; HPO-DAEE: hydroperoxy-2-decenoic acid ethyl ester; HO-1: heme oxygenase-1; iNOS: inducible nitric oxide synthase; MDA: malondialdehyde; NO: nitric oxide; NF-κB: nuclear factor kappa-light-chain-enhancer of activated B cells; Nrf2/ARE: nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxidant responsive elements (AREs); SOD: superoxide dismutase; TAC: total antioxidant capacity; TBARS: thiobarbituric acid reactive substances; TNF-α: tumor necrosis factor alpha; TTM: total thiol molecules; ↓: decrease; ↑: increase; ∗∗the effect depended on used dose.